Written answers

Wednesday, 23 November 2022

Department of Health

Medicinal Products

Photo of Róisín ShortallRóisín Shortall (Dublin North West, Social Democrats)
Link to this: Individually | In context | Oireachtas source

161. To ask the Minister for Health if he will provide further details regarding the proposed process to address thalidomide survivors’ longstanding concerns; the timeline that he is working towards; and if a chair will be appointed by 1 December 2022. [58447/22]

Photo of Anne RabbitteAnne Rabbitte (Galway East, Fianna Fail)
Link to this: Individually | In context | Oireachtas source

The Taoiseach and I had a constructive engagement with the Irish Thalidomide Association last Thursday, 17 November 2022.

Following a lengthy discussion, both sides agreed to enter into a process on a range of issues.

Engagement is underway on the format of that process, including the appointment of an independent chair, with a view to its commencement on 1 December 2022.

I want to assure survivors of thalidomide of the Government’s commitment to provide survivors with the necessary health and personal social service supports to meet their related needs. There is a designated senior manager in the Health Service Executive who liaises with Irish thalidomide survivors and on request assists them to access supports towards their ongoing health and personal social service needs.

Photo of Bernard DurkanBernard Durkan (Kildare North, Fine Gael)
Link to this: Individually | In context | Oireachtas source

162. To ask the Minister for Health the grounds upon which evusheld which is used to prevent Covid-19 was not considered for emergency authorisation; and if he will make a statement on the matter. [58186/22]

Photo of Stephen DonnellyStephen Donnelly (Wicklow, Fianna Fail)
Link to this: Individually | In context | Oireachtas source

As this is a service matter, I have asked the Health Service Executive to respond to the deputy directly as soon as possible.

Comments

No comments

Log in or join to post a public comment.